Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

The FDA has granted approval to an act of compassionate use treatment with the anti-cancer drug Namodenoson for a patient ...

As a breast cancer survivor, I feel it is incumbent upon me to give an accurate picture of cancer to others, particularly ...

Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...

Dr. Regina Hampton highlighted unmet needs in black women with breast cancer and details how genomic information can drive ...

The FDA has approved Keytruda plus chemotherapy in HER2+ gastric or GEJ adenocarcinoma with PD-L1–positive expression, based on KEYNOTE-811 data.

Fruzaqla given in combination with sintilimab slowed progression in the second line for those with locally advanced or metastatic renal cell carcinoma.

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...

After being diagnosed with colon cancer, I learned the life-changing lessons of self-love, stepping out of my comfort zone ...

Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...

Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...